158 related articles for article (PubMed ID: 19788873)
21. Monte Carlo simulation and the clinical laboratory.
Connelly DP; Willard KE
Arch Pathol Lab Med; 1989 Jul; 113(7):750-7. PubMed ID: 2742456
[TBL] [Abstract][Full Text] [Related]
22. Systems biology in drug discovery.
Butcher EC; Berg EL; Kunkel EJ
Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465
[TBL] [Abstract][Full Text] [Related]
23. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
24. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies.
Du W; Elemento O
Oncogene; 2015 Jun; 34(25):3215-25. PubMed ID: 25220419
[TBL] [Abstract][Full Text] [Related]
25. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
26. Pathology practice and pharmacogenomics.
Trent RJ
Pharmacogenomics; 2010 Jan; 11(1):105-11. PubMed ID: 20017676
[TBL] [Abstract][Full Text] [Related]
27. Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis.
Baranzini SE
Autoimmunity; 2006 Dec; 39(8):651-62. PubMed ID: 17178562
[TBL] [Abstract][Full Text] [Related]
28. Do we see what we think we see? The complexities of morphological assessment.
Hamilton PW; van Diest PJ; Williams R; Gallagher AG
J Pathol; 2009 Jul; 218(3):285-91. PubMed ID: 19291709
[TBL] [Abstract][Full Text] [Related]
29. Analysis of complex decision-making processes in health care: cognitive approaches to health informatics.
Kushniruk AW
J Biomed Inform; 2001 Oct; 34(5):365-76. PubMed ID: 12123153
[TBL] [Abstract][Full Text] [Related]
30. Combat against cancer with science and medicine.
Chow LW; Toi M
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S3-4. PubMed ID: 20374027
[No Abstract] [Full Text] [Related]
31. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
32. Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma.
Tadeo I; Piqueras M; Montaner D; Villamón E; Berbegall AP; Cañete A; Navarro S; Noguera R
Pediatr Res; 2014 Feb; 75(2):302-14. PubMed ID: 24216542
[TBL] [Abstract][Full Text] [Related]
33. Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration.
Agur Z; Elishmereni M; Kheifetz Y
Wiley Interdiscip Rev Syst Biol Med; 2014; 6(3):239-53. PubMed ID: 24604755
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics linkage of heterogeneous clinical and genomic information in support of personalized medicine.
Frey LJ; Maojo V; Mitchell JA
Yearb Med Inform; 2007; ():98-105. PubMed ID: 17700912
[TBL] [Abstract][Full Text] [Related]
35. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
36. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
37. Current status and challenges of personalized treatment of cancer: view inspired by the workshop.
Souchelnytskyi S
Exp Oncol; 2011 Sep; 33(3):166-9. PubMed ID: 21956472
[No Abstract] [Full Text] [Related]
38. Cytomics in predictive medicine.
Valet GK; Tárnok A
Cytometry B Clin Cytom; 2003 May; 53(1):1-3. PubMed ID: 12717684
[TBL] [Abstract][Full Text] [Related]
39. Clinical prediction rules: new opportunities for pharma.
Herscu P; Hoover TA; Randolph AG
Drug Discov Today; 2009 Dec; 14(23-24):1143-9. PubMed ID: 19853059
[TBL] [Abstract][Full Text] [Related]
40. Modeling metabolism: a window toward a comprehensive interpretation of networks in cancer.
Resendis-Antonio O; González-Torres C; Jaime-Muñoz G; Hernandez-Patiño CE; Salgado-Muñoz CF
Semin Cancer Biol; 2015 Feb; 30():79-87. PubMed ID: 24747697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
